| Subject | Predicate | Object | Context |
|---|---|---|---|
| http://www.reactome.org/bio... | rdf:type | biopax3:Evidence | lld:biopax3 |
| http://www.reactome.org/bio... | biopax3:comment | After aberrantly dimerizing in response to mesenchymally expressed ligands, FGFR2c S252W and P253R mutants are assumed to undergo transautophosphorylation analagous to the wild-type receptor, although this has not been explicitly demonstrated. Knock-down or chemical inhibition of other FGFR2-activating mutations identified in endometrial cancer cells has been shown to cause cell death (Byron, 2008). | lld:biopax3 |
| http://www.reactome.org/bio... | biopax3:xref | http://identifiers.org/pubm... | lld:biopax3 |
| http://www.reactome.org/bio... | biopax3:evidenceCode | http://www.reactome.org/bio... | lld:biopax3 |
| http://www.reactome.org/bio... | biopax3:evidence | http://www.reactome.org/bio... | lld:biopax3 |